KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Amortizatization of Intangibles: 2014-2024

Historic Amortizatization of Intangibles for Sarepta Therapeutics (SRPT) over the last 8 years, with Dec 2024 value amounting to -$40.3 million.

  • Sarepta Therapeutics' Amortizatization of Intangibles rose 89.33% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.7 million, marking a year-over-year increase of 74.97%. This contributed to the annual value of -$40.3 million for FY2024, which is 12.78% up from last year.
  • Sarepta Therapeutics' Amortizatization of Intangibles amounted to -$40.3 million in FY2024, which was up 12.78% from -$46.2 million recorded in FY2023.
  • In the past 5 years, Sarepta Therapeutics' Amortizatization of Intangibles registered a high of -$102,000 during FY2021, and its lowest value of -$46.2 million during FY2023.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was -$40.3 million (2024), whereas its average is -$32.4 million.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first crashed by 10,342.16% in 2022, then grew by 12.78% in 2024.
  • Sarepta Therapeutics' Amortizatization of Intangibles (Yearly) stood at -$102,000 in 2021, then plummeted by 10,342.16% to -$10.7 million in 2022, then plummeted by 333.54% to -$46.2 million in 2023, then climbed by 12.78% to -$40.3 million in 2024.